Introduction
iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at the interface of precision cancer medicine and digital health, with the aim of advancing research and providing innovative solutions to tackle cancer.
iCAN News and Events
Bayer Drug Development Simulation Brings the Realities of Pharmaceutical R&D to Life
As part of the iCANPOD/iCANDOC Workshop Series: Perspectives in Precision Cancer Medicine inand Outside Academia, iCANDOC hosted the Bayer Drug…
BioFinland Pitching Competition motivated Arina Värä to develop and pitch her business idea based on her iCANDOC doctoral research project – with winning results
Arina Värä, a doctoral researcher at iCANDOC Doctoral Education Pilot in Precision Cancer Medicine studies Boron neutron capture therapy (BNCT)…
iCAN Science Meetup
Welcome to the iCAN Science Meetup with poster exhibition November 25, 2026 at 14.00-18.30 in Biomedicum Lecture Hall 1 Register…
iCAN in Numbers
iCAN Study Participants
Company collaborations
iCAN Publications
Invention
Disclosures
Patents
External Funding
